| SC 13D/A | 2023-09-28 | CPMG Inc | REATA PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-09-28 | BIOGEN INC. | REATA PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-09-26 | ROSE WILLIAM | REATA PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-09-19 | ROSE WILLIAM | REATA PHARMACEUTICALS INC | 3,182,950 | 8.9% | EDGAR |
| SC 13D/A | 2023-08-24 | ROSE WILLIAM | REATA PHARMACEUTICALS INC | 3,240,950 | 9.1% | EDGAR |
| SC 13D | 2023-08-07 | BIOGEN INC. | REATA PHARMACEUTICALS INC | 8,936,791 | 23.4% | EDGAR |
| SC 13D/A | 2023-08-01 | CPMG Inc | REATA PHARMACEUTICALS INC | 4,589,758 | 13.2% | EDGAR |
| SC 13D/A | 2023-07-31 | ROSE WILLIAM | REATA PHARMACEUTICALS INC | 3,240,950 | 9.2% | EDGAR |
| SC 13G | 2023-06-26 | ADAGE CAPITAL PARTNERS GP, L.L.C. | REATA PHARMACEUTICALS INC | 1,730,841 | 5.2% | EDGAR |
| SC 13G/A | 2023-05-15 | First Light Asset Management, LLC | REATA PHARMACEUTICALS INC | 1,290,193 | 3.9% | EDGAR |
| SC 13G | 2023-03-07 | PERCEPTIVE ADVISORS LLC | REATA PHARMACEUTICALS INC | 2,083,799 | 6.5% | EDGAR |
| SC 13G/A | 2023-02-14 | Point72 Asset Management, L.P. | REATA PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | First Light Asset Management, LLC | REATA PHARMACEUTICALS INC | 2,155,552 | 6.8% | EDGAR |
| SC 13G/A | 2023-02-10 | EcoR1 Capital, LLC | REATA PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | REATA PHARMACEUTICALS INC | 2,705,656 | 8.5% | EDGAR |
| SC 13G/A | 2023-02-03 | BlackRock Inc. | REATA PHARMACEUTICALS INC | 2,501,693 | 7.9% | EDGAR |
| SC 13G | 2022-09-22 | Point72 Asset Management, L.P. | REATA PHARMACEUTICALS INC | 1,650,400 | 5.2% | EDGAR |
| SC 13G/A | 2022-09-09 | WELLINGTON MANAGEMENT GROUP LLP | REATA PHARMACEUTICALS INC | 1,508,638 | 4.8% | EDGAR |
| SC 13G | 2022-04-11 | EcoR1 Capital, LLC | REATA PHARMACEUTICALS INC | 1,975,611 | 6.3% | EDGAR |
| SC 13G/A | 2022-03-10 | Invesco Ltd. | REATA PHARMACEUTICALS INC | 372,165 | 1.2% | EDGAR |